Larotrectinib treatment of advanced TRK fusion thyroid cancer

被引：33

作者：

Cabanillas, M. E. ^{[1
]}

Drilon, A. ^{[2
]}

Farago, A. F. ^{[3
]}

Brose, M. S. ^{[4
]}

McDermott, R. ^{[5
]}

Sohal, D. ^{[6
]}

Oh, D-Y. ^{[7
]}

Almubarak, M. ^{[8
]}

Bauman, J. ^{[9
]}

Chu, E. ^{[10
]}

Kummar, S. ^{[11
]}

Leyvraz, S. ^{[12
]}

Park, K. ^{[13
]}

Reeves, J. A. ^{[14
]}

Dima, L. ^{[14
]}

Maeda, P. ^{[14
]}

Rodrigues, L. ^{[15
]}

Brega, N. ^{[14
]}

Hong, D. S. ^{[16
]}

Waguespack, S. G. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA

[2] Mem Sloan Kettering Canc Ctr, Early Drug Dev, 1275 York Ave, New York, NY 10021 USA

[3] Massachusetts Gen Hosp, Ctr Thorac Canc, Boston, MA 02114 USA

[4] Univ Penn, Otorhinolaryngol Head & Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA

[5] St Vincents Univ Hosp, Med Oncol, Dublin, Ireland

[6] Univ Cincinnati, Internal Med, Cincinnati, OH USA

[7] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea

[8] West Virginia Univ, Med, Morgantown, WV 26506 USA

[9] Fox Chase Canc Ctr, Head & Neck & Thorac Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[10] UPMC Hillman Canc Ctr, Med, Pittsburgh, PA USA

[11] Stanford Univ, Stanford Canc Inst, Med, Palo Alto, CA 94304 USA

[12] Charite, Dept Oncol & Hematol, Ctr Comprehens Canc, Berlin, Germany

[13] Samsung Med Ctr, Hematol Oncol, Seoul, South Korea

[14] Bayer Healthcare Pharmaceut Inc, Oncol, Whippany, NJ 07981 USA

[15] Bayer SA, Oncol, Sao Paulo, Brazil

[16] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.1404

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1916P

引用

页码：S1086 / S1086

页数：1